IXICO (LON:IXI) Trading Down 12.2% – Here’s Why

IXICO plc (LON:IXI)’s stock price was down 12.2% during trading on Thursday . The stock traded as low as GBX 8.56 and last traded at GBX 9. Approximately 2,252,712 shares traded hands during mid-day trading, an increase of 1,835% from the average daily volume of 116,391 shares. The stock had previously closed at GBX 10.25.

IXICO Stock Performance

The firm’s 50-day simple moving average is GBX 11.32 and its two-hundred day simple moving average is GBX 11.64. The company has a current ratio of 2.85, a quick ratio of 4.90 and a debt-to-equity ratio of 3.32. The stock has a market capitalization of £8.34 million, a PE ratio of -4.86, a PEG ratio of -0.38 and a beta of 0.86.

IXICO (LON:IXI) last released its earnings results on Tuesday, December 9th. The company reported GBX (1.85) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. On average, equities research analysts expect that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.